Literature DB >> 14665441

Potentiating role of IGFBP-2 on IGF-II-stimulated alkaline phosphatase activity in differentiating osteoblasts.

Claudia Palermo1, Paola Manduca, Elisabetta Gazzerro, Luca Foppiani, Daniela Segat, Antonina Barreca.   

Abstract

The insulin-like growth factor (IGF) system plays an important role in the autocrine and paracrine regulation of bone formation and remodeling. The aim of this study was to evaluate the role of the autocrine IGF system during osteogenic differentiation in rat tibial osteoblasts (ROB) in culture. In this in vitro model, the stages of osteogenesis studied were S1, corresponding to the onset of alkaline phosphatase (AP) expression (days 0-3); S2, coincident with the peak of AP expression in differentiation culture conditions (days 4-6), and S3, corresponding to the onset of mineral deposition in the extracellular matrix (days 7-9). The results showed that conditioned medium of ROB contains greater amounts of IGF-II than IGF-I at all differentiation stages. Both peptides showed the highest concentrations on day 3 of differentiation (end of S1). All IGF-binding proteins (IGFBPs), except IGFBP-1 and -6, were detected, and IGFBP-2 was the most abundant IGFBP present in the conditioned media, and its degradation increased from S1 to S3. By semiquantitative RT-PCR, IGF-I and IGF-II were highly expressed on days 3 and 6, whereas IGFBP-2 was constantly expressed. We focused our study on the role of IGF-II and IGFBP-2 on the synthesis of AP, an early marker of osteoblast maturation. The results showed that a significant increase in AP expression was induced by IGF-II added to the differentiating osteoblasts continuously or in S1 but not in S2 or S3. IGFBP-2 was able to potentiate endogenous and exogenous IGF-II-dependent stimulation of AP activity, and its proteolytic degradation in late stages of osteogenesis (S2 and S3) was highly correlated with the increase of active matrix metalloproteinase-2 in the CM and with the decreased efficacy of IGF-II action. These data suggest that IGFBP-2, at nearly equimolar concentration with IGF-II, plays a potentiating role in IGF-II action on ROB differentiation in vitro.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14665441     DOI: 10.1152/ajpendo.00049.2003

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  18 in total

Review 1.  The role of the insulin‑like growth factor (IGF) axis in osteogenic and odontogenic differentiation.

Authors:  H Al-Kharobi; R El-Gendy; D A Devine; J Beattie
Journal:  Cell Mol Life Sci       Date:  2014-04       Impact factor: 9.261

2.  Estrogen Stimulation of Pleiotrophin Enhances Osteoblast Differentiation and Maintains Bone Mass in IGFBP-2 Null Mice.

Authors:  Gang Xi; Victoria E Demambro; Susan D'Costa; Shalier K Xia; Zach C Cox; Clifford J Rosen; David R Clemmons
Journal:  Endocrinology       Date:  2020-04-01       Impact factor: 4.736

3.  Temporal profiling and pulsed SILAC labeling identify novel secreted proteins during ex vivo osteoblast differentiation of human stromal stem cells.

Authors:  Lars P Kristensen; Li Chen; Maria Overbeck Nielsen; Diyako W Qanie; Irina Kratchmarova; Moustapha Kassem; Jens S Andersen
Journal:  Mol Cell Proteomics       Date:  2012-07-16       Impact factor: 5.911

4.  The heparin-binding domain of IGFBP-2 has insulin-like growth factor binding-independent biologic activity in the growing skeleton.

Authors:  Masanobu Kawai; Anne C Breggia; Victoria E DeMambro; Xinchun Shen; Ernesto Canalis; Mary L Bouxsein; Wesley G Beamer; David R Clemmons; Clifford J Rosen
Journal:  J Biol Chem       Date:  2011-03-03       Impact factor: 5.157

5.  Osteosarcopenia in Reproductive-Aged Women with Polycystic Ovary Syndrome: A Multicenter Case-Control Study.

Authors:  Maryam Kazemi; Brittany Y Jarrett; Stephen A Parry; Anna E Thalacker-Mercer; Kathleen M Hoeger; Steven D Spandorfer; Marla E Lujan
Journal:  J Clin Endocrinol Metab       Date:  2020-09-01       Impact factor: 5.958

Review 6.  Insulin like growth factor-I: a critical mediator of the skeletal response to parathyroid hormone.

Authors:  Daniel D Bikle; Yongmei Wang
Journal:  Curr Mol Pharmacol       Date:  2012-06       Impact factor: 3.339

7.  miR-30e targets IGF2-regulated osteogenesis in bone marrow-derived mesenchymal stem cells, aortic smooth muscle cells, and ApoE-/- mice.

Authors:  Wen Ding; Jihe Li; Jayanti Singh; Razan Alif; Roberto I Vazquez-Padron; Samirah A Gomes; Joshua M Hare; Lina A Shehadeh
Journal:  Cardiovasc Res       Date:  2015-02-12       Impact factor: 10.787

8.  Crosstalks between integrin alpha 5 and IGF2/IGFBP2 signalling trigger human bone marrow-derived mesenchymal stromal osteogenic differentiation.

Authors:  Zahia Hamidouche; Olivia Fromigué; Jochen Ringe; Thomas Häupl; Pierre J Marie
Journal:  BMC Cell Biol       Date:  2010-06-23       Impact factor: 4.241

9.  Igfbp2 Deletion in Ovariectomized Mice Enhances Energy Expenditure but Accelerates Bone Loss.

Authors:  Victoria E DeMambro; Phuong T Le; Anyonya R Guntur; David E Maridas; Ernesto Canalis; Kenichi Nagano; Roland Baron; David R Clemmons; Clifford J Rosen
Journal:  Endocrinology       Date:  2015-07-31       Impact factor: 4.736

10.  IGFBP-2 directly stimulates osteoblast differentiation.

Authors:  Gang Xi; Christine Wai; Victoria DeMambro; Clifford J Rosen; David R Clemmons
Journal:  J Bone Miner Res       Date:  2014-11       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.